Medical cannabis

Medical cannabis at pharmaceutical quality

A specialist wholesaler for pharmacies and prescribers. From GACP cultivation to EU-GMP release, fully documented.

Nexopharm GmbH is a pharmaceutical specialty wholesaler based in Düsseldorf, authorised under § 52a AMG, supplying German pharmacies with medical cannabis to GMP- and GDP-compliant standards. Every batch is documented with a batch-specific Certificate of Analysis (CoA) and released by a Qualified Person.

Nexopharm is a specialist pharmaceutical wholesaler focused on medical cannabis. We import, test and distribute cannabis medicines to pharmacies and stationary trade, based on our German wholesale authorisation (§ 52a AMG) and § 4 MedCanG. Our standard: pharmaceutical precision in every batch, not volume.

Quality you can measure

  • An unbroken chain from GACP cultivation to EU-GMP processing, with final release by a Qualified Person (QP).
  • Batch-specific Certificates of Analysis (CoA) to DAB and Ph. Eur.
  • Contaminant screening: heavy metals, pesticides (EU limits), mycotoxins, pyrrolizidine alkaloids.
  • No sterilisation with genotoxic ethylene oxide; validated, AMRadV-compliant methods instead.

A dependable supply chain (GDP)

  • GDP-compliant storage and distribution via a specialised logistics partner.
  • Temperature monitoring and batch traceability across the entire chain.
  • A focused, curated portfolio for predictable availability.

Who we serve

  • Pharmacies (including compounding under § 11 ApBetrO).
  • Prescribing physicians (professional information).
  • Wholesale and distribution partners.

Frequently asked questions

Does Nexopharm supply pharmacies with medical cannabis directly?

Yes. Nexopharm is a pharmaceutical wholesaler authorised under § 52a AMG and supplies pharmacies and authorised institutions under § 47 AMG directly. After professional (Fachkreis) verification, pharmacies gain access to specifications, Certificates of Analysis and personal consultation.

What quality evidence does Nexopharm provide for each batch?

Every batch is documented with a batch-specific Certificate of Analysis (CoA) to DAB and Ph. Eur. Testing covers contaminant screening for heavy metals, pesticides, mycotoxins and pyrrolizidine alkaloids. Final release is performed by a Qualified Person.

How is the GDP-compliant supply chain safeguarded?

Storage and distribution are GDP-compliant via specialised logistics partners with continuous temperature monitoring and full batch traceability — from goods-in to delivery at the pharmacy.

Is medical cannabis sterilised with ethylene oxide?

No. Nexopharm does not sterilise with genotoxic ethylene oxide and uses only validated, AMRadV-compliant methods.

How do pharmacies become customers of Nexopharm?

Pharmacies register via the professional (Fachkreis) access and confirm their authorisation under § 47 AMG. After verification, specifications, Certificates of Analysis and a dedicated contact — rather than an anonymous hotline — are available.

Authorisations & standards
§ 52a AMGWholesale authorisation§ 4 MedCanGMedical Cannabis ActEU-GMPProcessing partnerGDPcompliant distributionGACPCultivation standardAccredited contract lab

Nexopharm GmbH · Düsseldorf · Düsseldorf Local Court HRB 110093 · VAT ID DE457137529

Product details for verified professionals

Verified healthcare professionals can access specifications, Certificates of Analysis (CoA) and the full portfolio after sign-in.

Professional login